Osteologie is a distinguished journal published by GEORG THIEME VERLAG KG, focusing on advancing knowledge in the field of osteology and related medical disciplines. With an ISSN of 1019-1291 and E-ISSN 2567-5818, this journal plays a pivotal role in disseminating research that addresses bone health, osteoporotic conditions, and skeletal disorders. Despite its current ranking in Q4 within the broad category of Medicine (miscellaneous), and a Scopus rank placing it at the 15th percentile, Osteologie serves as a platform for emerging research and opinions in a multidisciplinary context. Curating content from 1999 to 2024, it provides valuable insights to researchers, professionals, and students keen on enhancing their understanding of bone health and its implications on overall well-being. With access options available through various academic channels, this journal remains an essential resource for those committed to the exploration and advancement of osteological science.

The Journal of Clinical Medicine is a premier peer-reviewed open-access journal published by MDPI, based in Switzerland. Since its inception in 2012, the journal has carved a niche for itself in the field of medicine, evidenced by its impressive ranking in the 2023 Scopus Ranks, where it stands at #80 out of 636 in General Medicine, placing it in the top 87th percentile. It endeavors to disseminate cutting-edge research that spans various disciplines within medicine, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access available since its launch, the journal ensures that significant medical findings are accessible to a global audience, fostering knowledge exchange and collaboration that is essential in today's rapidly evolving healthcare landscape. The journal's dedication to quality and innovation is further highlighted by its Q1 classification in the 2023 category quartiles for Medicine (miscellaneous), underlining its commitment to advancing clinical knowledge and practice.

Turk Osteoporoz Dergisi - Turkish Journal of Osteoporosis, published by GALENOS PUBL HOUSE, is a vital resource for researchers and practitioners in the field of endocrinology, diabetes, and metabolism, with a specific focus on osteoporosis. Since its inception as an open-access journal in 2002, it serves to disseminate significant findings and advancements in osteoporosis research, enabling wider access to knowledge in a critical area of health that affects millions worldwide. Despite earning a Q4 categorization in 2023 within its relevant quartile ranks and being positioned at the 7th percentile among its peers in Scopus’ Endocrinology, Diabetes, and Metabolism rankings, the journal actively contributes to the dialogue on osteoporosis, covering essential topics from pathophysiology to treatment strategies. Researchers and professionals can access its contents freely, promoting collaboration and innovation in this dynamic field of study. With an ISSN of 2147-2653, this journal continues to pave the way for improved understanding and management of osteoporosis, making it a cornerstone publication for both seasoned experts and emerging scholars in Turkey and beyond.

Acta Otorrinolaringologica Espanola, published by Elsevier Espana SLU, is a leading journal in the field of Otorhinolaryngology, dedicated to advancing the understanding and treatment of ear, nose, and throat disorders. With a history dating back to 1973 and an established reputation for rigorously peer-reviewed research, this journal plays a pivotal role in disseminating significant findings to both clinicians and researchers. Although it is currently categorized in the Q3 quartile for 2023, ranking 72 out of 123 in its field, it serves as a vital platform for the exploration of innovative concepts and clinical practices, contributing to a deeper understanding of otolaryngological issues. While the journal is not open access, it continues to attract a wide readership due to its comprehensive articles and impactful studies. Positioned in Barcelona, Spain, this journal provides a critical resource for professionals and scholars aiming to enhance their knowledge and improve clinical outcomes in Otorhinolaryngology.

JOURNAL OF BONE AND MINERAL METABOLISM, published by SPRINGER JAPAN KK, is a leading peer-reviewed journal dedicated to advancing the field of bone and mineral research since its establishment in 1988. With ISSN 0914-8779 and E-ISSN 1435-5604, this esteemed journal offers a platform for high-quality research that intersects Endocrinology, Diabetes and Metabolism, Orthopedics and Sports Medicine, and related disciplines. Recognized for its rigorous standards, it holds a commendable Q2 ranking in multiple categories, reflecting its broad influence and relevance in contemporary medical research. Researchers and practitioners alike benefit from its evidence-based articles and insights, which contribute significantly to our understanding of metabolic bone diseases and mineral homeostasis. Although not an open-access journal, it still provides essential information and advancements crucial for professionals and scholars dedicated to improving clinical outcomes and enhancing patient care in these vital areas. To learn more, please explore the journal's archives and latest publications.

Current Osteoporosis Reports, published by Springer, is a premier journal dedicated to advancing the understanding of osteoporosis and related metabolic bone diseases. With its ISSN 1544-1873 and E-ISSN 1544-2241, this esteemed publication has established itself as a vital resource in the field of endocrinology, diabetes, and metabolism, evidenced by its Q1 ranking and 82nd percentile in Scopus. Spanning from 2003 to 2024, the journal seeks to disseminate high-quality research, critical reviews, and comprehensive reports that address the complexities of osteoporosis, offering insights into diagnosis, treatment, and prevention strategies. Although not an open-access journal, Current Osteoporosis Reports ensures that researchers, healthcare professionals, and students have access to cutting-edge scientific knowledge that fuels innovative approaches to improving patient care and outcomes. The journal's impact in shaping the dialogue and research landscape in its domain underscores its importance for anyone invested in improving bone health.

Bone & Joint Research is a prestigious open access journal published by the British Editorial Society of Bone & Joint Surgery, which has been serving the orthopedic and surgical community since its inception in 2012. With an impact factor reflecting its high standards and relevance within the field, this journal boasts impressive Scopus rankings, positioning it in the Q1 category for both Orthopedics and Sports Medicine and Surgery as of 2023. Located in the United Kingdom, the journal aims to disseminate cutting-edge research, clinical studies, and innovative approaches to treatment in musculoskeletal health, making it an indispensable resource for researchers, healthcare professionals, and students alike. The journal encourages a collaborative discourse that fosters advancements in the understanding and treatment of bone and joint diseases, fulfilling its mission to enhance patient outcomes and improve the quality of care.

Bone Reports is a premier, peer-reviewed journal published by Elsevier that has been committed to advancing the field of orthopedics, sports medicine, and endocrinology since its inception as an open-access journal in 2015. With an ISSN of 2352-1872, this esteemed publication seeks to disseminate high-quality research that spans a diverse array of topics related to bone health, metabolic diseases, and musculoskeletal disorders. The journal boasts an impressive impact factor, contributing significantly to its recognition, with a Q2 ranking in Orthopedics and Sports Medicine and a Q3 ranking in Endocrinology, Diabetes, and Metabolism as of 2023. This open-access model enhances accessibility and engagement, allowing researchers, professionals, and students alike to stay at the forefront of developments in these critical areas. With an emphasis on rigorous methodology and innovative findings, Bone Reports is poised to become a vital resource for anyone interested in the latest advances in bone research and clinical applications.

BREAST CANCER RESEARCH, published by BMC, is a prestigious open-access journal dedicated to advancing the field of oncology with a specific focus on breast cancer. Since its inception in 1999, the journal has established itself as a leading platform for disseminating high-quality research, with an impressive impact factor and recognition in the Q1 category for both Cancer Research and Oncology as of 2023. The journal is ranked 45th out of 404 in the field of Medicine _ Oncology and 37th out of 230 in Biochemistry, Genetics and Molecular Biology _ Cancer Research, placing it in the top echelons of research quality and relevance at 88th and 84th percentiles, respectively. BREAST CANCER RESEARCH is committed to facilitating rapid and open access to groundbreaking findings, making it an invaluable resource for researchers, healthcare professionals, and students striving to enhance their understanding of breast cancer mechanisms, treatments, and prevention strategies. With its base in the United Kingdom, the journal continues to foster international collaborations and discussions aimed at improving patient outcomes and enriching cancer research worldwide.

Bone Research is a premier open-access journal published by SpringerNature, dedicated to advancing the understanding of bone biology and its related disciplines. Established in 2013 and based in the United Kingdom, this journal has quickly ascended to the forefront of scientific inquiry, evidenced by its esteemed Q1 rankings in 2023 across multiple categories including Endocrinology, Diabetes and Metabolism, Histology, and Physiology. With a commendable impact reflected in its Scopus ranks—positioned #2 in Histology, #9 in Endocrinology, and #8 in Physiology—Bone Research serves as a vital platform for researchers, healthcare professionals, and students alike to share and access cutting-edge findings. Since adopting an open-access model in 2014, the journal has empowered an expansive audience by facilitating immediate availability of high-quality research. This aligns with its commitment to foster innovation and collaboration within the fields it encompasses. As it converges its efforts from 2013 to 2024, Bone Research remains a critical resource for those looking to deepen their investigation into bone health and diseases, ensuring its place as a leader in promoting scientific excellence.